Clinical Trial

Circulating Tumor DNA in Soft Tissue Sarcoma

Study Description

Circulating Tumor DNA in Soft Tissue Sarcoma

This research study will collect blood and tumor tissue samples from patients with soft tissue sarcoma to look at circulating tumor deoxyribonucleic acid (DNA). When tumor cells are damaged or die, DNA from the tumor cells are released into the blood stream as the cells break down. This is called circulating tumor DNA. Circulating tumor DNA is an important biomarker that may be used in cancer detection, prediction of treatment response, and disease monitoring.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Procedure - Archival tumor tissue collection and blood draws

Archival tumor tissue will be collected for testing of circulating tumor DNA. Blood draws will be taken for testing of circulating tumor DNA.

Additional Information

Official Study Title

Circulating Tumor DNA Detection in Soft Tissue Sarcoma (DNA-TSAR)

Clinical Trial ID

NCT03818412

ParticipAid ID

azpY7d